Ireland
--:--IST
Latest
Clinical Trials in France / NCT07436312
Recruiting Not applicable

Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer

NCT07436312 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-05-04
Last updated
2026-05-08

Condition(s) studied

Breast CancerPancreas CancerColon CancerLynch SyndromeGermline BRCA1 Gene MutationGermline BRCA2 Gene Mutation

Investigational drug(s) / intervention(s)

educational workshop on nutrition + additional intervention on UPF tool and how to use it

educational workshop on nutrition + additional intervention on UPF tool and how to use it: Participants with WCRF score at baseline ≤ 5 will be randomized at 1:1 ratio between intervention group (educational workshop on nutrition + additional intervention on UPF tool and how to use it) and control group (educational workshop on nutrition only). Impact will be assessed at 12 weeks with the WCRF questionnaire.

Study summary

The U-TRANS study was initiated by Gustave Roussy, which is its sponsor\*. It is part of the Interception Program and aims to reduce the consumption of ultra-processed foods in order to improve the overall quality of the diet among people at high risk of cancer (WCRF score ≤ 5, corresponding to low adherence to nutritional cancer prevention recommendations: eating a diet rich in whole grains, vegetables, fruit and fibre, and limiting ultra-processed foods, red meat, processed meats, sugary drinks and alcohol). It assesses the impact of a digital intervention (based on the use of the Open Food Facts app) as a complement to the nutritional education provided by the Interception program.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Age \> 18 years, 2. Individuals at increased risk of different cancers as defined within the Interception program, 3. With a baseline WCRF score ≤ 5 at entry in the Interception program, 4. Agreeing to participate and who have given their written agreement for the study, 5. Agreeing to fill in the questionnaires on the dedicated platform for the duration of the study, 6. Participant have and accept to use their smartphone, 7. All participants must understand spoken and written French language Exclusion Criteria: 1. Psychiatric disorders or cognitive impairments precluding participation, 2. Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Institut Sainte Catherine Avignon France Not Yet Recruiting
Eugène Marquis Rennes France Recruiting
Gustave Roussy Villejuif France Recruiting

More Gustave Roussy, Cancer Campus, Grand Paris trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07436312 on ClinicalTrials.gov ↗ ← All trials in France